Shop

PureBioMedical™ - "Where PURE innovation meets PURE science!"™ > Products > PureBMC® TWO 120mL
PureBMC® TWO 120mL
PureBMC® TWO 120mL - Image 2
PureBMC® TWO 120mL - Image 3
PureBMC® TWO 120mL - Image 4

PureBMC® TWO 120mL

Optimize your regenerative treatments with the EmCyte 120ml PureBMC Kit, a sophisticated dual-spin Bone Marrow Aspirate Concentrate (BMC) solution designed for superior performance and compatibility. Tailored for use with the Executive Series II and Platinum Centrifuges, this kit offers a reliable and efficient method for processing bone marrow aspirate.

Key Features:

  • Dual Spin Technology: Utilizes an advanced dual-spin process to concentrate bone marrow aspirate effectively, enhancing the regenerative properties of the BMC.
  • High Capacity: Designed to process up to 120ml of bone marrow aspirate, accommodating a wide range of treatment needs and patient requirements.
  • Centrifuge Compatibility: Fully compatible with the EmCyte Executive Series II and Platinum Centrifuges, ensuring seamless integration with your existing equipment.
Inquiry
Categories: , Tag:

Description

 

There is a clear reason for the success of PurePRP® SP. It has the perfect cellular composition at ideal concentrations. It is a clinical marvel that’s not duplicated anywhere. PurePRP® SP provides the most powerful concentration of deliverable regenerative cells, without the deleterious contaminants found in most PRP products. The system exceeds the clinical requirement for effective PRP, providing between 7 and 21 billion platelets in a treatment sample. Unlike most PRP systems today, it DOES NOT create a diabetic condition at the injection site, of which is known to counter effective wound healing. The system removes red blood cell content, which is known to cause pain and inflammation at the injection site and it gives the practitioner control over its neutrophil content, allowing them to selectively treat wounds that require antimicrobial debridement or controlled inflammatory responses. The combined capability of PurePRP SP is unmatched at the point of care.

Leading in biologic power

PureBMC® SupraPhysiologic is autologous bone marrow concentrate (BMC) that’s clinically accepted modern progenitor stem cell medicine that’s used in the treatment of various pathologies. It supports tissue healing and regeneration through a cell milieu that comprises of a concentrated combination of differentiating stem cells consisting of hematopoietic, mesenchymal, and total nucleated cells, in addition to platelets and other cell mediators and cytokines.  The use of PureBMC® is a point of care minimally invasive biologic that adds the power of self-renewal and differentiation to biologic therapies for musculoskeletal pathologies, spinal disorders, chronic wound care, and critical limb ischemia and a host of other wounds and injuries.  It is an effective treatment in the rapidly growing field of regenerative medicine. PureBMC® SupraPhysiologic is the state of the art in bone marrow concentrating system that leads with biologic power, safety, efficiency and clinical outcomes.

Less clotting

Material mediated coagulation studies show there is no statistical significant difference between the clotting time of plasma and PureBMC SupraPhysiologic (SP). Quiescent aspiration of bone marrow using the ASPIRE Harvesting System reduces activation clotting which helps to maintain cell function during collection and processing. This shows that PureBMC SP is processed in a manner that preserves the functionality of progenitor stem cells, platelets, and platelet growth factor.

Less free hemoglobin

Extracellular free hemoglobin molecules are known to trigger pathologies associated with adverse clinical outcomes. This includes oxidative reactivity that leads to nitrous oxide depletion, oxidative stress, hypertension, vaso-occlusion, immune dysregulation, renal failure and more. PureBMC® SP prepares a pure sample of bone marrow concentrate with the least amount of free hemoglobin, when compared to other leading systems. Its unique collection removes hemolytic free hemoglobin.

Less activation

PureBMC® has a progenitor cell viability of 97% or greater, partially due to its gentle processing technique and quiescent aspiration attained with the ASPIRE™ bone marrow needle. it is equipped with an ergonomic and lightweight handle for even application of pressure during deployment, a razor sharp triple crown bevel tip for minimally invasive coring of the cortical bone, and a specially designed fenestrated blunt tip aspirating cannula for purified sample collection.

Related products